Agios Pharmaceuticals | AGIO - Ebitda

Precio De Mercado
28.33
Cambio Diario
0.28 1.00%
Mensual
-16.26%
Anual
-8.44%
Q2 Expectativa
24.78




Ebitda Cambio Fecha
AbbVie USD 5.37B 1.85B 2025-12
Agios Pharmaceuticals USD -120.31M 4.82M 2025-12
Alnylam Pharmaceuticals USD 145.22M 236.56M 2025-12
Amgen USD 5.14B 775M 2025-12
Arrowhead Research USD 64.2M 223.53M 2025-09
Astellas Pharma JPY 98.93B 84.75B 2026-03
AstraZeneca USD 5.67B 1.29B 2026-03
Bayer EUR 1.97B 457M 2025-12
Biogen USD 649.7M 76.5M 2026-03
BioMarin Pharmaceutical USD -24.17M 18.91M 2025-12
Bristol-Myers Squibb USD 2.88B 1.36B 2025-12
Daiichi Sankyo JPY 101.6B 22.81B 2025-03
Eli Lilly USD 12.14B 4.26B 2025-12
Exelixis USD 248.93M 28.02M 2025-09
Gilead Sciences USD 3.02B 1.01B 2025-12
GlaxoSmithKline GBP 2.77B 1.65B 2026-03
Incyte USD 414.5M 92.42M 2025-12
Ionis Pharmaceuticals USD -200.02M 42.89M 2025-12
Merck USD 6.3B 2.09B 2025-12
Moderna USD -790M 582M 2025-12
Nektar Therapeutics USD -31.81M 70K 2023-09
Novartis USD 5.3B 530M 2026-03
Novartis USD 5.84B 235M 2025-09
Pfizer USD 6.08B 351M 2025-09
Puma Biotechnology USD 729K 11.36M 2024-06
Regeneron Pharmaceuticals USD 1.2B 718.4M 2025-12
Roche Holding CHF 12.68B 2.36B 2024-06
Sarepta Therapeutics USD -168.03M 294.45M 2025-09
Vertex Pharmaceuticals USD 1.44B 100.4M 2025-09